IP association: lack of data protection hinders drug development
Weak data protection rules in eight major economies are hurting US drug development companies, according to a major trade association of intellectual property owners.
To read more
Subscribe to Global Data Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Data Review experts.